Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
03/16/2005 | CN1593547A Method for preparing compound medicinal capsule and powder for nourishing yin |
03/16/2005 | CN1593545A Method for preparing health preserving compound capsule and powder |
03/16/2005 | CN1593544A Method for preparing compound Chinese medicinal tonifying liquor |
03/16/2005 | CN1593543A Method for preparing compound Chinese medicinal tonifying liquor |
03/16/2005 | CN1593542A Method for preparing compound Chinese medicinal tonifying wine |
03/16/2005 | CN1593541A Method for preparing compound Chinese medicinal tonifying capsule and powder |
03/16/2005 | CN1593527A Dispersible tablet of 'Duyiwei' and its preparing method |
03/16/2005 | CN1593508A Chinese traditional medicine for treating gastroenteritic diseases and its preparation process |
03/16/2005 | CN1593507A Chinese prepared drug for treating gastropathy and its preparation method |
03/16/2005 | CN1593491A Plaster for treating infantile hernia and initial stage lymphoid tuberculosis |
03/16/2005 | CN1593484A Bone strengthening granule of tortoise plastron and astragalus root |
03/16/2005 | CN1593473A Application of a pharmaceutical composition in the preparing process of medicine for treating chronic alcohol intake caused injury |
03/16/2005 | CN1593472A Pharmaceutical composition for treating liver diseases and its application |
03/16/2005 | CN1593470A Compound linolenic acid preparation |
03/16/2005 | CN1593467A Method for extracting medicinal and edible substance from dictyoptera |
03/16/2005 | CN1593466A Simple prescription of earthworm oral liquid for treating alveolar bone resorption and its preparing method |
03/16/2005 | CN1593462A Insulin secretory cell extract and its application in inducing stem cell differentiation |
03/16/2005 | CN1593438A Aseptic diammonium glycyrrhizinate powder injection and its preparation |
03/16/2005 | CN1593431A Pharmaceutical composition for protecting liver |
03/16/2005 | CN1593426A Medicine for treating animal enterogastritis and its preparing method |
03/16/2005 | CN1593409A Entogastric stagnating controlled release preparation of kurarinone |
03/16/2005 | CN1593403A Colon positioning and adhering preparation and its preparing process |
03/16/2005 | CN1593393A Prescription of liquid status of Vitamin K1 and its preparation |
03/16/2005 | CN1593389A Cool plaster and its processing method and usage |
03/16/2005 | CN1193036C Method of preparing clarithromycin of form II crystals |
03/16/2005 | CN1193026C Z-pyrazoline-5-ones |
03/16/2005 | CN1193025C Novel 1, 3-dihydro-2H-indol-2-one derivatives, their preparing method and pharmceutical composition containing the same |
03/16/2005 | CN1193024C Process for producing optically active sulfoxide devivative' |
03/16/2005 | CN1193003C Aminobenzophenones as inhibitors of IL-1 beta and TNF-alpha |
03/16/2005 | CN1192787C Chinese medicine for treating ulcerative colitis and its preparing process |
03/16/2005 | CN1192775C Prophylactic and therapeutic use of oltipraz as antifibrotic and anticirrhotic agent in liver and pharmaceutical composition containing oltipraz |
03/16/2005 | CN1192767C Capsule and binding agent for pharmaceutical formulations with improved storage stability |
03/16/2005 | CN1192728C Health-care cigarette |
03/15/2005 | US6867299 Inosine monophosphate dehydrogenase (IMPDH); use as immunosuppressants, anticancer agents and antiviral agents |
03/15/2005 | US6867226 Preventing diarrhea |
03/15/2005 | US6867220 Phenoxypropanolamines, method for producing them and pharmaceutical compositions containing them |
03/15/2005 | US6867211 Fused nitrogen biheterocyclic derivatives; immunomodulaters; inhibiting cytokine release |
03/15/2005 | US6867205 Useful for the treatment and/or prophylaxis of diseases associated with dipeptidyl peptidase, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance |
03/15/2005 | US6867204 Benzoxazine derivatives and uses thereof |
03/15/2005 | US6867193 Prevents onset of hepatic encephalopathy |
03/15/2005 | US6866851 GFRα1-RET specific agonists and methods therefor |
03/15/2005 | CA2323047C Prodrugs of benzofuranylmethyl carbamate nk, antagonists |
03/15/2005 | CA2246595C Novel atropisomers of 2,3-disubstituted-(5,6)-heteroarylfused-pyrimidin-4-ones |
03/15/2005 | CA2217515C Pharmaceutical composition containing proton pump inhibitors |
03/15/2005 | CA2063671C Aminoguanidines |
03/10/2005 | WO2005021792A1 Preventive or remedy for inflammatory bowel diseases containing anti-cd81 antibody as the active ingredient |
03/10/2005 | WO2005021776A2 METHODS OF USING MAMMALIAN RNase H AND COMPOSITIONS THEREOF |
03/10/2005 | WO2005021555A1 Bicyclic piperazine compound and use thereof |
03/10/2005 | WO2005021539A1 Benzimidazolone compounds having 5-ht4 receptor agonistic activity |
03/10/2005 | WO2005021534A1 1,3-dihydro-2h-indol-2-one derivative |
03/10/2005 | WO2005021013A1 β-HYDROXY SHORT TO MEDIUM CHAIN FATTY ACID POLYMER |
03/10/2005 | WO2005021009A2 Formulations and methods of treating inflammatory bowel disease |
03/10/2005 | WO2005020997A1 Compositions for veterinary and medical applications |
03/10/2005 | WO2005020937A1 Composition for application to tooth |
03/10/2005 | WO2004078172A3 Sod mimic multifunctional compounds for treating inflammatory bowel disease |
03/10/2005 | WO2004041794A8 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines |
03/10/2005 | WO2003104260A3 Pharmaceutical formulation |
03/10/2005 | WO2003010290A3 Novel class ii cytokine receptors and uses thereof |
03/10/2005 | US20050054825 Osteogenic devices |
03/10/2005 | US20050054729 Combined with a statin, ACE-inhibitor, PDE V-inhibitor, Ca-antagonist, beta-blocker, arginine, or tetrahydrobiopterin; treating of conditions including cardiovascular disorders, erectile dysfunction, therapy and prophylaxis of diabetes including its complicatons, and respiratory diseases |
03/10/2005 | US20050054728 Oral and rectal drug delivery of a mixture of 4-aminophenylacetic acid and 5-aminosalicylic acid; antiinflammatory agents for gastrointestinal tract; antiulcer agents |
03/10/2005 | US20050054711 with a substituted benzene ring; agonists of the progesterone receptorinducing contraception treating progesterone-related carcinomas and adenocarcinomas |
03/10/2005 | US20050054706 N-substituted pyrroles, pyrazoles, imidazoles, triazoles and tetrazoles used for treating and preventing cancer, inflammation, autoimmune diseases, respiratory system disorders, septic shock, pain, preterm labor, as dietetics and sexual disorders, and disorders associated with MAP kinases |
03/10/2005 | US20050054675 Interferon $g(g) production promoter |
03/10/2005 | US20050054668 Antagonists of MCP-1 function and methods of use thereof |
03/10/2005 | US20050054661 Irritable bowel disorders; anxiolytic agents; antidepressants |
03/10/2005 | US20050054656 Therapy for obesity, eating disorders, psychological disorders, antidepressants, central nervous system disorders |
03/10/2005 | US20050054641 Propanolaminomethyltetralines, their preparation and pharmaceutical composition comprising same |
03/10/2005 | US20050054611 Composition and method for use in intestinal cleansing procedures |
03/10/2005 | US20050054602 Oligonucleotides containing activated lymphocytes; antibody therapy; antiallergens; skin disorders |
03/10/2005 | US20050054593 New drug |
03/10/2005 | US20050054587 Novel therapeutic indication of azithromycin for treatment of non-infective inflamatory diseases |
03/10/2005 | US20050054582 Para-amino benzoic acids as integrin antagonists |
03/10/2005 | US20050054581 Somatostatin antagonists and agonists that act at the sst subtype 2 receptor |
03/10/2005 | US20050054580 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells |
03/10/2005 | US20050054577 Irritable bowel disorders; controlling permeability of intestine tissue ; anticholinergic agent |
03/10/2005 | US20050054564 Proteins for use in treatment of gastrointestinal disorders; novel gene product designated Antrum Mucosal Protein 18 ("AMP-18") is a gastrokine |
03/10/2005 | US20050054102 Culturing preferential stem cells and generating pancreatic beta cell tissues via transfection for use in treatment of diabetes, hyperglycemia, and/or impaired glucose tolerance; tissue engineering; regenerative medicine |
03/10/2005 | US20050054041 Kini-3 motor protein and methods for its use |
03/10/2005 | US20050054036 Growth factor isoform |
03/10/2005 | US20050053935 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer |
03/10/2005 | US20050053914 Nucleotide sequences coding hepatitis envelope protein for use as tool in detecting hepactocyte receptors; drug screening, viricides and treatment of viral diseases |
03/10/2005 | US20050053676 Powdered composition for use as laxative |
03/10/2005 | US20050053660 Multi-particulate form of medicament, comprising at least two differently coated forms of pellet |
03/10/2005 | US20050053641 Method of treating irritable bowel syndrome |
03/10/2005 | US20050053603 Monocyte chemoattractant protein for treatment of liver diseases and antibodies thereof |
03/10/2005 | US20050053556 Administering subcitrate, aluminate, oxide, salicylate, subgallate, stannate, phosphate, tribromphenate, subcarbonatate, subnitrate, and/or sodium tartrate salt of bismuth to treat halitosis associated with sulfite-reducing bacteria in gut |
03/10/2005 | CA2535923A1 Formulations and methods of treating inflammatory bowel disease |
03/09/2005 | EP1512415A1 Decoy composition for treating and preventing inflammatory disease |
03/09/2005 | EP1512008A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action |
03/09/2005 | EP1511774A1 Per (3,6-anhydro) cyclodextrin derivatives, their preparation and use thereof for separating ions, in particular chromium and manganese anions |
03/09/2005 | EP1511765A1 Par-2-activating peptide derivative and pharmaceutical composition using the same |
03/09/2005 | EP1511759A1 Modulators and inhibitors of fibroblast growth factor receptor 5-polypeptides and gene expression thereof. |
03/09/2005 | EP1511751A1 Pyrazolo[1,5-a]pyrimidine compounds as antiviral agents |
03/09/2005 | EP1511744A2 Bis-benzimidazoles and related compounds as potassium channel modulators |
03/09/2005 | EP1511743A1 Pyrazole-derivatives as p38 kinase inhibitors |
03/09/2005 | EP1511737A1 Aryloximes |
03/09/2005 | EP1511736A1 Therapeutic molecules and methods-1 |
03/09/2005 | EP1511728A2 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics |
03/09/2005 | EP1511727A2 Aromatic sulfones and their medical use |